The novel coronavirus has exposed deeply rooted disparities across the healthcare system which disproportionately impact communities of color. The way to begin to pave the way for lasting change? Inclusive innovation, community outreach and policy work—and a passion for fighting for an equitable future.
For the 35th year in a row, Johnson & Johnson has been named to Working Mother's 100 Best Companies list—and these two employees were named Working Mother and Working Dad of the Year for their incredible strength in the face of adversity.
Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., were just honored with the prestigious award for their work with gene-editing technology CRISPR. But they also have a connection to Johnson & Johnson—they were awarded the Dr. Paul Janssen Award in 2014. Learn more about what makes them so impressive.
When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.
Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
Smart glasses with remote access capabilities. Track-and-trace sensors powered by GPS. These are just two cutting-edge technologies the company has tapped to help keep its supply chain running smoothly at manufacturing and shipping facilities around the world.
From epidemic masks that the company introduced during the Spanish flu pandemic to work it's doing today on an investigational COVID-19 vaccine, learn how the company has been at the forefront of safeguarding global public health for well over a century.
Early in his career Daniel Cua, Ph.D., made a discovery that would lead to a new medication for the debilitating autoimmune disease. We sat down with Dr. Cua, known as "the father" in his field of study, to learn what his work could mean for those with psoriatic arthritis.
The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
As the International AIDS Society Conference kicks off virtually this year, we sat down with three attendees, including activist and actress Laverne Cox, to talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.
As the European Commission grants Marketing Authorization forthe company's Ebola vaccine regimen—a key step towards enabling broader access to it for the people who need it most—we share top facts about the vaccine for the deadly virus.